Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary hemochromatosis adjustment in transfusion‑dependent anemia with early low‑dose deferasirox
KCT0003715Phase 2Recruiting
- Sponsor
- Shinpoong Pharma
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of deferasirox in Secondary Hemosiderosis, sponsored by Shinpoong Pharma. Started Oct 2019; status: recruiting.
02
Drugs
deferasirox
03
Conditions
Secondary Hemosiderosis
Beyond the preview
Go deeper on KCT0003715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003715.